Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127236) titled 'A Multicenter, Prospective, Randomized Controlled Study of Oxazepam Combined with Escitalopram for the Treatment of Anxiety Disorders with Depression' on June 26.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Affiliated Kangning Hospital of Ningbo University
Condition:
Anxiety disorder with depression
Intervention:
experimental group:Oxazepam combined with escitalopram oxalate
Oxazepam, 15-30 mg, PO, q.d.-t.i.d.
Escitalopram Oxalate, 10-20mg, PO, q.d.-t.i.d.
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-07-01
Target Sample Size: experimental gro...